Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stamler, J.
Right arrow Articles by Wentworth, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stamler, J.
Right arrow Articles by Wentworth, D.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 16, Issue 2 434-444, Copyright © 1993 by American Diabetes Association

ARTICLES

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

J Stamler, O Vaccaro, JD Neaton and D Wentworth
Department of Preventive Medicine, Northwestern University Medical School, Chicago, Illinois 60611-4402.

OBJECTIVE--To assess predictors of CVD mortality among men with and without diabetes and to assess the independent effect of diabetes on the risk of CVD death. RESEARCH DESIGN AND METHODS--Participants in this cohort study were screened from 1973 to 1975; vital status has been ascertained over an average of 12 yr of follow-up (range 11-13 yr). Participants were 347,978 men aged 35-57 yr, screened in 20 centers for MRFIT. The outcome measure was CVD mortality. RESULTS--Among 5163 men who reported taking medication for diabetes, 1092 deaths (603 CVD deaths) occurred in an average of 12 yr of follow-up. Among 342,815 men not taking medication for diabetes, 20,867 deaths were identified, 8965 ascribed to CVD. Absolute risk of CVD death was much higher for diabetic than nondiabetic men of every age stratum, ethnic background, and risk factor level--overall three times higher, with adjustment for age, race, income, serum cholesterol level, sBP, and reported number of cigarettes/day (P < 0.0001). For men both with and without diabetes, serum cholesterol level, sBP, and cigarette smoking were significant predictors of CVD mortality. For diabetic men with higher values for each risk factor and their combinations, absolute risk of CVD death increased more steeply than for nondiabetic men, so that absolute excess risk for diabetic men was progressively greater than for nondiabetic men with higher risk factor levels. CONCLUSIONS--These findings emphasize the importance of rigorous sustained intervention in people with diabetes to control blood pressure, lower serum cholesterol, and abolish cigarette smoking, and the importance of considering nutritional-hygienic approaches on a mass scale to prevent diabetes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
J. Shearer, D. L. Severson, L. Su, L. Belardinelli, and A. K. Dhalla
Partial A1 Adenosine Receptor Agonist Regulates Cardiac Substrate Utilization in Insulin-Resistant Rats in Vivo
J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 306 - 311.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
American Diabetes Association
Standards of Medical Care in Diabetes--2009
Diabetes Care, January 1, 2009; 32(Supplement_1): S13 - S61.
[Full Text] [PDF]

Home page
 JAMAHome page
A. Doria, J. Wojcik, R. Xu, E. V. Gervino, T. H. Hauser, M. T. Johnstone, D. Nolan, F. B. Hu, and J. H. Warram
Interaction Between Poor Glycemic Control and 9p21 Locus on Risk of Coronary Artery Disease in Type 2 Diabetes
JAMA, November 26, 2008; 300(20): 2389 - 2397.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Hu, J. D. Klein, J. Du, and X. H. Wang
Cardiac Muscle Protein Catabolism in Diabetes Mellitus: Activation of the Ubiquitin-Proteasome System by Insulin Deficiency
Endocrinology, November 1, 2008; 149(11): 5384 - 5390.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Z. Ravid, M. Bendayan, E. Delvin, A. T. Sane, M. Elchebly, J. Lafond, M. Lambert, G. Mailhot, and E. Levy
Modulation of intestinal cholesterol absorption by high glucose levels: impact on cholesterol transporters, regulatory enzymes, and transcription factors
Am J Physiol Gastrointest Liver Physiol, November 1, 2008; 295(5): G873 - G885.
[Abstract] [Full Text] [PDF]

Home page
 ptjournalHome page
A. D Deshpande, M. Harris-Hayes, and M. Schootman
Epidemiology of Diabetes and Diabetes-Related Complications
Physical Therapy, November 1, 2008; 88(11): 1254 - 1264.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
R. A Kloner, J. Neutel, E. M Roth, R. Weiss, M. H Weinberger, K. M Thakker, B. Schwartz, H. Shi, A.-M. Gregg, and the ADHT Investigators
Blood Pressure Control with Amlodipine Add-on Therapy in Patients with Hypertension and Diabetes: Results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial
Ann. Pharmacother., November 1, 2008; 42(11): 1552 - 1562.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. R. Holman, S. K. Paul, M. A. Bethel, H. A. W. Neil, and D. R. Matthews
Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes
N. Engl. J. Med., October 9, 2008; 359(15): 1565 - 1576.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
U. Khanderia, R. Pop-Busui, and K. A Eagle
Thiazolidinediones in Type 2 Diabetes: A Cardiology Perspective
Ann. Pharmacother., October 1, 2008; 42(10): 1466 - 1474.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
M. Huelsmann, S. Neuhold, G. Strunk, D. Moertl, R. Berger, R. Prager, H. Abrahamian, M. Riedl, R. Pacher, A. Luger, et al.
NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus
Eur. Heart J., September 2, 2008; 29(18): 2259 - 2264.
[Abstract] [Full Text] [PDF]

Home page
 J CARDIOVASC PHARMACOL THERHome page
J. C. Ferrer-Garcia, E. Sanchez-Ballester, R. Albalat-Galera, M. Berzosa-Sanchez, and A. Herrera-Ballester
Efficacy of Atorvastatin for Achieving Cholesterol Targets After LDL-Cholesterol Based Dose Selection in Patients With Type 2 Diabetes
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2008; 13(3): 183 - 188.
[Abstract] [PDF]

Home page
 CMAJHome page
X. Yang PhD, W. So MBChB, G. T.C. Ko MD, R. C.W. Ma MBChB, A. P.S. Kong MBChB, C.-C. Chow MBBS, P. C.Y. Tong PhD, and J. C.N. Chan MD
Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus
Can. Med. Assoc. J., August 26, 2008; 179(5): 427 - 437.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
K. I. Shoghi, R. J. Gropler, T. Sharp, P. Herrero, N. Fettig, Y. Su, M. S. Mitra, A. Kovacs, B. N. Finck, and M. J. Welch
Time Course of Alterations in Myocardial Glucose Utilization in the Zucker Diabetic Fatty Rat with Correlation to Gene Expression of Glucose Transporters: A Small-Animal PET Investigation
J. Nucl. Med., August 1, 2008; 49(8): 1320 - 1327.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
V. A. Fonseca, J. Rosenstock, A. C. Wang, K. E. Truitt, and M. R. Jones
Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy
Diabetes Care, August 1, 2008; 31(8): 1479 - 1484.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. J. Nicholls, E. M. Tuzcu, S. Kalidindi, K. Wolski, K.-W. Moon, I. Sipahi, P. Schoenhagen, and S. E. Nissen
Effect of Diabetes on Progression of Coronary Atherosclerosis and Arterial Remodeling: A Pooled Analysis of 5 Intravascular Ultrasound Trials
J. Am. Coll. Cardiol., July 22, 2008; 52(4): 255 - 262.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes Spectr.Home page
C. Triplitt and C. A. Alvarez
Best Practices for Lowering the Risk of Cardiovascular Disease in Diabetes
Diabetes Spectr, July 1, 2008; 21(3): 177 - 189.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. A. Molenaar, S.-J. Hwang, R. S. Vasan, D. E. Grobbee, J. B. Meigs, R. B. D'Agostino Sr., D. Levy, and C. S. Fox
Burden and Rates of Treatment and Control of Cardiovascular Disease Risk Factors in Obesity: The Framingham Heart Study
Diabetes Care, July 1, 2008; 31(7): 1367 - 1372.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. G. Dluhy and G. T. McMahon
Intensive Glycemic Control in the ACCORD and ADVANCE Trials
N. Engl. J. Med., June 12, 2008; 358(24): 2630 - 2633.
[Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
S. L. Norris, D. Kansagara, C. Bougatsos, and R. Fu
Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force
Ann Intern Med, June 3, 2008; 148(11): 855 - 868.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. De Wit, C. A. Sabin, R. Weber, S. W. Worm, P. Reiss, C. Cazanave, W. El-Sadr, A. d. Monforte, E. Fontas, M. G. Law, et al.
Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
Diabetes Care, June 1, 2008; 31(6): 1224 - 1229.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
S. S Lund, L. Tarnow, C. D A Stehouwer, C. G Schalkwijk, T. Teerlink, J. Gram, K. Winther, M. Frandsen, U. M Smidt, O. Pedersen, et al.
Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes
Eur. J. Endocrinol., May 1, 2008; 158(5): 631 - 641.
[Abstract] [Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
S. Choi, S. Rankin, A. Stewart, and R. Oka
Perceptions of Coronary Heart Disease Risk in Korean Immigrants With Type 2 Diabetes
The Diabetes Educator, May 1, 2008; 34(3): 484 - 492.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
B. Hohenstein, C. P.M. Hugo, B. Hausknecht, K. P. Boehmer, R. H. Riess, and R. E. Schmieder
Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy
Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1346 - 1354.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. Cheurfa, D. Dubois-Laforgue, D. A.F. Ferrarezi, A. F. Reis, G. M. Brenner, C. Bouche, C. Le Feuvre, F. Fumeron, J. Timsit, M. Marre, et al.
The Common -866G>A Variant in the Promoter of UCP2 Is Associated With Decreased Risk of Coronary Artery Disease in Type 2 Diabetic Men
Diabetes, April 1, 2008; 57(4): 1063 - 1068.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
P. Korhonen, P. Aarnio, T. Saaresranta, P. Jaatinen, and I. Kantola
Glucose Homeostasis in Hypertensive Subjects
Hypertension, April 1, 2008; 51(4): 945 - 949.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
K. L. Ong, A. W.K. Tso, K. S.L. Lam, and B. M.Y. Cheung
Gender Difference in Blood Pressure Control and Cardiovascular Risk Factors in Americans With Diagnosed Hypertension
Hypertension, April 1, 2008; 51(4): 1142 - 1148.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. J.L. Murray, R. H. Dias, S. C. Kulkarni, R. Lozano, G. A. Stevens, and M. Ezzati
Improving the Comparability of Diabetes Mortality Statistics in the U.S. and Mexico
Diabetes Care, March 1, 2008; 31(3): 451 - 458.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. Turchin, M. Shubina, A. H. Chodos, J. S. Einbinder, and M. L. Pendergrass
Effect of Board Certification on Antihypertensive Treatment Intensification in Patients With Diabetes Mellitus
Circulation, February 5, 2008; 117(5): 623 - 628.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
Y. Takata, H. Osawa, M. Kurata, M. Kurokawa, J. Yamauchi, M. Ochi, W. Nishida, T. Okura, J. Higaki, and H. Makino
Hyperresistinemia Is Associated With Coexistence of Hypertension and Type 2 Diabetes
Hypertension, February 1, 2008; 51(2): 534 - 539.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Bianchi, R. Miccoli, G. Penno, and S. Del Prato
Primary Prevention of Cardiovascular Disease in People With Dysglycemia
Diabetes Care, February 1, 2008; 31(Supplement_2): S208 - S214.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. O. Stirban and D. Tschoepe
Cardiovascular Complications in Diabetes: Targets and interventions
Diabetes Care, February 1, 2008; 31(Supplement_2): S215 - S221.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. M. Nilsson
Is Weight Loss Beneficial for Reduction of Morbidity and Mortality?: What is the controversy about?
Diabetes Care, February 1, 2008; 31(Supplement_2): S278 - S283.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
S. S Lund, L. Tarnow, M. Frandsen, U. M Smidt, O. Pedersen, H.-H. Parving, and A. A Vaag
Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes
Eur. J. Endocrinol., January 1, 2008; 158(1): 35 - 46.
[Abstract] [Full Text] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
J. Pedro-Botet
Review: The role of fenofibrate in reducing cardiovascular risk in type 2 diabetes
The British Journal of Diabetes & Vascular Disease, January 1, 2008; 8(1): 22 - 27.
[Abstract] [PDF]

Home page
 J Am Coll Cardiol ImgHome page
T. Amano, T. Matsubara, T. Uetani, M. Nanki, N. Marui, M. Kato, T. Yoshida, K. Arai, K. Yokoi, H. Ando, et al.
Abnormal Glucose Regulation Is Associated With Lipid-Rich Coronary Plaque: Relationship to Insulin Resistance
J. Am. Coll. Cardiol. Img., January 1, 2008; 1(1): 39 - 45.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
F. Rigo, R. Sicari, S. Gherardi, A. Djordjevic-Dikic, L. Cortigiani, and E. Picano
The additive prognostic value of wall motion abnormalities and coronary flow reserve during dipyridamole stress echo
Eur. Heart J., January 1, 2008; 29(1): 79 - 88.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Fernandez, C. Triplitt, E. Wajcberg, A. A. Sriwijilkamol, N. Musi, K. Cusi, R. DeFronzo, and E. Cersosimo
Addition of Pioglitazone and Ramipril to Intensive Insulin Therapy in Type 2 Diabetic Patients Improves Vascular Dysfunction by Different Mechanisms
Diabetes Care, January 1, 2008; 31(1): 121 - 127.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. S. Kim, G. Kewalramani, P. Puthanveetil, V. Lee, U. Kumar, D. An, A. Abrahani, and B. Rodrigues
Acute Diabetes Moderates Trafficking of Cardiac Lipoprotein Lipase Through p38 Mitogen-Activated Protein Kinase Dependent Actin Cytoskeleton Organization
Diabetes, January 1, 2008; 57(1): 64 - 76.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. Murao, X. Yu, H. Imachi, W. M. Cao, K. Chen, K. Matsumoto, T. Nishiuchi, N. C. W. Wong, and T. Ishida
Hyperglycemia suppresses hepatic scavenger receptor class B type I expression
Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E78 - E87.
[Abstract] [Full Text] [PDF]

Home page
 J Clin PharmacolHome page
Y.-L. He, M. Ligueros-Saylan, G. Sunkara, R. Sabo, C. Zhao, Y. Wang, J. Campestrini, F. Pommier, K. Dole, A. Marion, et al.
Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No Pharmacokinetic Interactions With the Antihypertensive Agents Amlodipine, Valsartan, and Ramipril in Healthy Subjects
J. Clin. Pharmacol., January 1, 2008; 48(1): 85 - 95.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
American Diabetes Association
Standards of Medical Care in Diabetes--2008
Diabetes Care, January 1, 2008; 31(Supplement_1): S12 - S54.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
G. Hu, P. Jousilahti, and J. Tuomilehto
Joint effects of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease
Eur. Heart J., December 2, 2007; 28(24): 3059 - 3066.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
A. Kapur and R. De Palma
Mortality after myocardial infarction in patients with diabetes mellitus
Heart, December 1, 2007; 93(12): 1504 - 1506.
[Abstract] [Full Text] [PDF]

Home page
 ANGIOLOGYHome page
S. Yologlu, A. T. Sezgin, N. Sezgin, E. Yetkin, and E. Olmez
Comparison of Different Regression Analyses for Identifying Risk Factors in Obese and Nonobese Patients With Coronary Artery Disease
Angiology, November 1, 2007; 58(5): 543 - 549.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
I. Z. Ben-Dov, D. Ben-Ishay, J. Mekler, L. Ben-Arie, and M. Bursztyn
Increased Prevalence of Masked Blood Pressure Elevations in Treated Diabetic Subjects
Arch Intern Med, October 22, 2007; 167(19): 2139 - 2142.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
L. Cortigiani, F. Rigo, S. Gherardi, R. Sicari, M. Galderisi, F. Bovenzi, and E. Picano
Additional Prognostic Value of Coronary Flow Reserve in Diabetic and Nondiabetic Patients With Negative Dipyridamole Stress Echocardiography by Wall Motion Criteria
J. Am. Coll. Cardiol., October 2, 2007; 50(14): 1354 - 1361.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
A. M. Lincoff, K. Wolski, S. J. Nicholls, and S. E. Nissen
Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Trials
JAMA, September 12, 2007; 298(10): 1180 - 1188.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
D. M. Riche and K. S. McClendon
Role of statins for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus
Am. J. Health Syst. Pharm., August 1, 2007; 64(15): 1603 - 1610.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
E. L.M. Barr, P. Z. Zimmet, T. A. Welborn, D. Jolley, D. J. Magliano, D. W. Dunstan, A. J. Cameron, T. Dwyer, H. R. Taylor, A. M. Tonkin, et al.
Risk of Cardiovascular and All-Cause Mortality in Individuals With Diabetes Mellitus, Impaired Fasting Glucose, and Impaired Glucose Tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)
Circulation, July 10, 2007; 116(2): 151 - 157.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
G. Hu, J. Tuomilehto, K. Silventoinen, C. Sarti, S. Mannisto, and P. Jousilahti
Body Mass Index, Waist Circumference, and Waist-Hip Ratio on the Risk of Total and Type-Specific Stroke
Arch Intern Med, July 9, 2007; 167(13): 1420 - 1427.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. D. Home, S. J. Pocock, H. Beck-Nielsen, R. Gomis, M. Hanefeld, N. P. Jones, M. Komajda, J. J.V. McMurray, and the RECORD Study Group
Rosiglitazone Evaluated for Cardiovascular Outcomes -- An Interim Analysis
N. Engl. J. Med., July 5, 2007; 357(1): 28 - 38.
[Abstract] [Full Text] [PDF]

Home page
 Asia Pac J Public HealthHome page
J. Wong, F. Tan, and P. Lee
The State of Lipid Control in Patients with Diabetes in a Public Health Care Centre
Asia Pac J Public Health, July 1, 2007; 19(3): 16 - 21.
[Abstract] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. F. Chowdhry, H. A. Vohra, and M. Galinanes
Diabetes increases apoptosis and necrosis in both ischemic and nonischemic human myocardium: Role of caspases and poly-adenosine diphosphate-ribose polymerase
J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 124 - 131.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
G. Ostling, B. Hedblad, G. Berglund, and I. Goncalves
Increased Echolucency of Carotid Plaques in Patients With Type 2 Diabetes
Stroke, July 1, 2007; 38(7): 2074 - 2078.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al.
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Eur. Heart J., June 11, 2007; (2007) ehm236v1.
[Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74.
[Full Text] [PDF]

Home page